Posted 2/25/2024 8:20 PM (GMT 0)
Dear Din.
At the beginning of March I will start radiotherapy sessions.
I decided to speak out because we have through a similar situation and my decisions can help you.
In June 2014, my robotic surgery took place. The pathology report was: G 8, EPE-, clear margins, LN-, SV- and my PSA was undetectable (<0.003) for 18 months.
When my PSA reached 0.05 (May/2019) I started the appointments with an oncologist. When the PSA reached 0.014 (November/2023) the oncologist requested an MRI of the prostatic fossa and to my surprise it was detected:
“Focal nodular change along the right posterolateral wall of the vesicourethral anastomosis, suspected of tissue with neovascularization and suspicion of viable neoplasia (PI-RR 5).
Discreet tissue thickening with a more nodular appearance and topography of an indeterminate right seminal vesicle (PI-RR 3).
Slightly prominent lymph node in the left external iliac chain, undetermined for secondary dissemination”
After that, he requested a PET-CT with Gallium68 PSMA to ensure that there were no metastases outside the pelvis. The diagnostic impression was as follows:
“There is no area of PSMA overexpression that suggests viable neoplasia in the surgical bed, lymph node disease or bone lesions suspicious for secondary implantation.”
I didn't expect the MRI would find something with such a low PSA. See that they carried out studies on this:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8887697/#:~:text=MRI%20can%20diagnose%20local%20prostate,the%20prostate%20bed%20than%20CT.